Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligation.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  American Journal of Pathology

• Publication date

  2006-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2353/AJPATH.2006.050747PMID 16651617PMCID PMC1606599
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Secretion of MCP-1/CCL2 by bile duct epithelia induces myofibroblastic transdifferentiation of portal fibroblasts.

  2006cited by this paper
• Renal fibrosis: new insights into the pathogenesis and therapeutics.

  2006cited by this paper
• Beta-cell-specific ablation of the hepatocyte growth factor receptor results in reduced islet size, impaired insulin secretion, and glucose intolerance.

  2005cited by this paper
• Transdifferentiation of rat hepatocytes into biliary cells after bile duct ligation and toxic biliary injury

  2005cited by this paper
• β-Cell-Specific Ablation of the Hepatocyte Growth Factor Receptor Results in Reduced Islet Size, Impaired Insulin Secretion, and Glucose Intolerance

  2005cited by this paper
• Liver fibrosis: from the bench to clinical targets.

  2004cited by this paper
• Hepatic stem cells: from inside and outside the liver?

  2004cited by this paper
• Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of action.

  2004cited by this paper
• Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention.

  2004cited by this paper
• A dual reporter gene transgenic mouse demonstrates heterogeneity in hepatic fibrogenic cell populations

  2004cited by this paper
• Overview of recent experimental studies on liver stem cells.

  2003cited by this paper
• Epithelial-mesenchymal transition and its implications for fibrosis.

  2003cited by this paper
• Downregulation of Smad transcriptional corepressors SnoN and Ski in the fibrotic kidney: an amplification mechanism for TGF-beta1 signaling.

  2003cited by this paper
• Targeted disruption of TGF-β1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction

  2003cited by this paper
• The epithelial mesenchymal transition confers resistance to the apoptotic effects of transforming growth factor Beta in fetal rat hepatocytes.

  2002cited by this paper
• Hepatocyte growth factor gene therapy and angiotensin II blockade synergistically attenuate renal interstitial fibrosis in mice.

  2002cited by this paper
• Evidence that fibroblasts derive from epithelium during tissue fibrosis.

  2002influential reference
• Hepatocytes undergo phenotypic transformation to biliary epithelium in organoid cultures

  2002cited by this paper
• Peribiliary myofibroblasts in biliary type liver fibrosis.

  2002cited by this paper
• Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis.

  2002cited by this paper
• Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy.

  2002cited by this paper
• Single injection of naked plasmid encoding hepatocyte growth factor prevents cell death and ameliorates acute renal failure in mice.

  2002cited by this paper
• Obstructive nephropathy and renal fibrosis.

  2002cited by this paper
• Fractal dimension can distinguish models and pharmacologic changes in liver fibrosis in rats

  2002cited by this paper
• Hepatic fibrosis--role of hepatic stellate cell activation.

  2002cited by this paper
• Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies.

  2002cited by this paper
• Hepatic fibrosis. Pathogenesis and principles of therapy.

  2001cited by this paper
• Replicative senescence of biliary epithelial cells precedes bile duct loss in chronic liver allograft rejection: increased expression of p21(WAF1/Cip1) as a disease marker and the influence of immunosuppressive drugs.

  2001cited by this paper
• Transforming growth factor beta and the liver.

  2001cited by this paper
• Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis.

  2001cited by this paper
• Hepatocyte growth factor: renotropic role and potential therapeutics for renal diseases.

  2001cited by this paper
• Hepatic Stellate Cells as a Target for the Treatment of Liver Fibrosis

  2001cited by this paper
• The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling

  2001cited by this paper
• Sustained expression of naked plasmid DNA encoding hepatocyte growth factor in mice promotes liver and overall body growth

  2001cited by this paper
• The development and compensation of biliary cirrhosis in interleukin-6-deficient mice.

  2000influential reference
• Fibrogenesis I. New insights into hepatic stellate cell activation: the simple becomes complex.

  2000cited by this paper
• Molecular basis of renal fibrosis

  2000cited by this paper
• Hepatic stellate cells: a target for the treatment of liver fibrosis

  2000cited by this paper
• Effects of growth and differentiation factors on the epithelial-mesenchymal transition in cultured neonatal rat hepatocytes.

  1999cited by this paper
• Hepatocyte growth factor gene therapy of liver cirrhosis in rats

  1999cited by this paper
• In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: a potential new therapy for hepatic fibrosis.

  1999cited by this paper
• Wholesale hepatocytic differentiation in the rat from ductular oval cells, the progeny of biliary stem cells.

  1997cited by this paper
• Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/cirrhosis

  1997cited by this paper
• Liver Regeneration

  1997cited by this paper
• Molecular mechanisms of hepatic fibrosis and principles of therapy

  1997cited by this paper
• Epithelial‐mesenchymal transition of cultured rat neonatal hepatocytes is differentially regulated in response to epidermal growth factor and dimethyl sulfoxide

  1997cited by this paper
• Antigenic phenotypes common to rat oval cells, primary hepatocellular carcinomas and developing bile ducts.

  1997cited by this paper
• Identification of bipotential progenitor cells in human liver regeneration.

  1996cited by this paper
• Ductular hepatocytes. Evidence for a bile ductular cell origin in furan-treated rats.

  1994cited by this paper
• Is the guinea pig a full negative model to study the carotid body mediated Chronic Intermittent Hypoxia effects

  1983cited by this paper
• Modifications of a specific assay for hydroxyproline in urine.

  1967cited by this paper
• Transforming Growth Factor (cid:1) and the Liver

  year unknowncited by this paper

• Hepatocyte–hepatic stellate cell interactions in liver fibrosis: Mechanisms and therapeutic implications

  2026cites this paper
• Single-staged in vivo co-transplantation of autologous muscular and urothelial micrografts as a composite tissue tube for urogenital reconstruction

  2026cites this paper
• Continuous Intravenous Infusion of Hepatocyte Growth Factor Promotes the Development of a Fibrolytic Phenotype in Hepatic Macrophages and Stellate Cells in a Rat Model of Bile Duct Ligation

  2025cites this paper
• Endothelial Cell Transition: Preliminary Data on Cross-Organ Shift from Brain to Liver

  2025cites this paper
• Hepatocyte Growth Factor-Modified Dental Pulp Stem Cells Potentially Regulate Novel Renal Fibrosis-Associated Gene via PI3K/AKT/GSK3β Pathway to Alleviate Renal Fibrosis

  2025cites this paper
• Nucleic acid spheres for treating capillarisation of liver sinusoidal endothelial cells in liver fibrosis

  2025cites this paper
• Mitigation of Methotrexate-Induced Intestinal Mucositis in Male Wistar Rats by Gallic Acid: The Role of HGF and C-Met Genes

  2025cites this paper
• Endoplasmic reticulum stress PERK-ATF4-CHOP pathway is involved in non-alcoholic fatty liver disease in type 1 diabetic rats: The rescue effect of treatment exercise and insulin-like growth factor I

  2024cites this paper
• Building in vitro models for mechanistic understanding of liver regeneration in chronic liver diseases.

  2024cites this paper
• A superior material with antithrombotic properties serves as a secure adsorbent for the elimination of bilirubin in vitro and in pig models

  2024cites this paper
• Oliveria decumbens Extract Exhibits Hepatoprotective Effects Against Bile Duct Ligation-Induced Liver Injury in Rats by Reducing Oxidative Stress

  2023cites this paper
• Pathological role of methionine in the initiation and progression of biliary atresia

  2023cites this paper
• Nanotechnology-based combinational strategies toward the regulation of myofibroblasts and diseased microenvironment in liver fibrosis and hepatic carcinoma

  2023cites this paper
• Stem cell pathology: histogenesis of malignant fibrous histiocytoma and characterization of myofibroblasts appearing in fibrotic lesions

  2023influential citation
• Ductular reaction in non-alcoholic fatty liver disease: When Macbeth is perverted

  2023cites this paper
• Targeting A-kinase anchoring protein 12 phosphorylation in hepatic stellate cells regulates liver injury and fibrosis in mouse models

  2022cites this paper
• Adipose-Derived Stem Cells (ADSCs) Supplemented with Hepatocyte Growth Factor (HGF) Attenuate Hepatic Stellate Cell Activation and Liver Fibrosis by Inhibiting the TGF-β/Smad Signaling Pathway in Chemical-Induced Liver Fibrosis Associated with Diabetes

  2022cites this paper
• Safety evaluation of hydroethanolic fruit extracts of Duranta erecta Linn

  2022cites this paper
• Empagliflozin exhibits hepatoprotective effects against bile duct ligation-induced liver injury in rats: a combined molecular docking approach to in vivo studies.

  2022cites this paper
• Human iPSCs for modeling of hepatobiliary development and drug discovery

  2022cites this paper
• cMet agonistic antibody prevents acute kidney injury to chronic kidney disease transition by suppressing Smurf1 and activating Smad7.

  2021cites this paper
• Hydroxyapatite reinforced inorganic-organic hybrid nanocomposite as high-performance adsorbents for bilirubin removal in vitro and in pig models

  2021cites this paper
• The metabolic and biochemical mapping of Agave americana leave juice encode their prospective biotechnological uses

  2021cites this paper
• Relationship between Hepatitis B virus infection and platelet production and dysfunction

  2021cites this paper
• Evaluation of the effect of heat shock protein 70 targeted drugs on cirrhotic cardiomyopathy in biliary cirrhotic rats.

  2021cites this paper
• Cxcl10 deficiency attenuates renal interstitial fibrosis through regulating epithelial-to-mesenchymal transition.

  2021cites this paper
• Liver donor age affects hepatocyte function through age-dependent changes in decellularized liver matrix.

  2021cites this paper
• Aliskiren and Fenofibrate Constrict Liver Fibrosis by means of Focusing on TGF-β1/Smad Signaling Pathway and Actuating HGF Expression

  2021cites this paper
• Study on the relationship between hepatic fibrosis and epithelial-mesenchymal transition in intrahepatic cells.

  2020cites this paper
• Hepatoprotective effect of the hydroalcoholic extract of Cichorium intybus in a rat model of obstructive cholestasis.

  2020cites this paper
• Decellularized hepatic extracellular matrix hydrogel attenuates hepatic stellate cell activation and liver fibrosis.

  2020cites this paper
• Intercellular crosstalk of hepatic stellate cells in liver fibrosis: new insights into therapy.

  2020cites this paper
• Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives

  2020influential citation
• c‐Met Signaling Is Essential for Mouse Adult Liver Progenitor Cells Expansion After Transforming Growth Factor‐β‐Induced Epithelial–Mesenchymal Transition and Regulates Cell Phenotypic Switch

  2019cites this paper
• Potential anti‐inflammatory and antioxidant effects of Citrus aurantium essential oil against carbon tetrachloride‐mediated hepatotoxicity: A biochemical, molecular and histopathological changes in adult rats

  2019cites this paper
• Inflammatory Effects of Subacute Exposure of Roundup in Rat Liver and Adipose Tissue

  2019cites this paper
• Effect of the transdifferentiation of BECs into myofibroblasts on the pathogenesis of secondary cholestatic hepatic fibrosis.

  2019cites this paper
• The Significance of NOTCH Pathway in the Development of Fibrosis in Systemic Sclerosis

  2019cites this paper
• Renoprotective effects of a novel cMet agonistic antibody on kidney fibrosis

  2019cites this paper
• Liver‐Targeted Angiotensin Converting Enzyme 2 Therapy Inhibits Chronic Biliary Fibrosis in Multiple Drug‐Resistant Gene 2‐Knockout Mice

  2019cites this paper
• Bariatric Surgery in Cirrhotic Patients: Is It Safe?

  2019cites this paper
• Mast cells and its crosstalk with mesenchymal cells in chronic lung diseases

  2019cites this paper
• Increased Expression of Adherens Junction Components in Mouse Liver following Bile Duct Ligation

  2019cites this paper
• Ron Receptor Signaling Ameliorates Hepatic Fibrosis in a Diet-Induced Nonalcoholic Steatohepatitis Mouse Model.

  2018cites this paper
• Coronary stents with inducible VEGF/HGF-secreting UCB-MSCs reduced restenosis and increased re-endothelialization in a swine model

  2018cites this paper
• Mitochondrial dysfunctions contribute to energy deficits in rodent model of hepatic encephalopathy

  2018cites this paper
• Interventional Potential of Recombinant Feline Hepatocyte Growth Factor in a Mouse Model of Non-alcoholic Steatohepatitis

  2018cites this paper
• New Concepts on Reversibility and Targeting of Liver Fibrosis; A Review Article

  2018cites this paper
• Ensemble of subspace discriminant classifiers for schistosomal liver fibrosis staging in mice microscopic images

  2018cites this paper
• Paclitaxel alleviates liver fibrosis induced by bile duct ligation in rats: Role of TGF‐&bgr;1, IL‐10 and c‐Myc

  2018cites this paper
• Targeting Endothelial Erk1/2-Akt Axis as a Regeneration Strategy to Bypass Fibrosis during Chronic Liver Injury in Mice.

  2018cites this paper
• Prolonged darkness reduces liver fibrosis in a mouse model of primary sclerosing cholangitis by miR‐200b down‐regulation

  2017cites this paper
• Conference Paper MINI REVIEW : LIVER FIBROSIS MECHANISM

  2017cites this paper
• The protective effect of vitamin D against carbon tetrachloride damage to the rat liver

  2017cites this paper
• Establishment of human hair follicle mesenchymal stem cells with overexpressed human hepatocyte growth factor

  2017cites this paper
• Date fruits inhibit hepatocyte apoptosis and modulate the expression of hepatocyte growth factor, cytochrome P450 2E1 and heme oxygenase-1 in carbon tetrachloride-induced liver fibrosis

  2017influential citation
• Platelets in liver disease, cancer and regeneration

  2017cites this paper
• Blood-Brain Barrier Permeability Is Exacerbated in Experimental Model of Hepatic Encephalopathy via MMP-9 Activation and Downregulation of Tight Junction Proteins

  2017cites this paper
• Papel de BMP9 en la patología hepática crónica: estudios "in vivo" e "in vitro"

  2017cites this paper
• The role of growth factors on hepatic damage in rats with obstructive jaundice

  2016cites this paper
• Revisiting Epithelial-to-Mesenchymal Transition in Liver Fibrosis: Clues for a Better Understanding of the “Reactive” Biliary Epithelial Phenotype

  2016cites this paper
• Heparin-binding epidermal growth factor-like growth factor and hepatocyte growth factor inhibit cholestatic liver injury in mice through different mechanisms

  2016cites this paper
• Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next Step

  2016cites this paper
• Antifibrotic Effects of Human Amniotic Membrane Transplantation in Established Biliary Fibrosis Induced in Rats

  2016cites this paper
• Antifibrotic Therapies: Where Are We Now?

  2016cites this paper
• Title Role of CD 56-expressing immature biliary epithelial cells inbiliary atresia

  2016cites this paper
• Liver fibrosis in bile duct-ligated rats correlates with increased hepatic IL-17 and TGF-β2 expression.

  2016cites this paper
• Novel functions of platelets in the liver

  2016cites this paper
• Epithelial-mesenchymal transition in liver fibrosis.

  2016cites this paper
• Epithelial-mesenchymal transition: An emerging target in tissue fibrosis

  2016cites this paper
• Role of CD56-expressing immature biliary epithelial cells in biliary atresia.

  2016cites this paper
• Epithelial-mesenchymal transition in liver fibrosis (Review)

  2016cites this paper
• Increased Expression of TGF-β Signaling Components in a Mouse Model of Fibrosis Induced by Submandibular Gland Duct Ligation

  2015cites this paper
• Potent natural products and herbal medicines for treating liver fibrosis

  2015cites this paper
• Role of stem cells during diabetic liver injury

  2015cites this paper
• Hepatic myofibroblasts and fibrogenic progression of chronic liver diseases.

  2015influential citation
• Pathogenesis of Type 2 Epithelial to Mesenchymal Transition (EMT) in Renal and Hepatic Fibrosis

  2015cites this paper
• Novel insights into the function and dynamics of extracellular matrix in liver fibrosis.

  2015cites this paper
• Treating morbid obesity in cirrhosis: A quest of holy grail.

  2015cites this paper
• Loss of Gab1 adaptor protein in hepatocytes aggravates experimental liver fibrosis in mice.

  2015cites this paper
• Yin-Chen-Hao-Tang alleviates biliary obstructive cirrhosis in rats by inhibiting biliary epithelial cell proliferation and activation

  2015cites this paper
• Enhanced Antioxidant Capacity of Dental Pulp-Derived iPSC-Differentiated Hepatocytes and Liver Regeneration by Injectable HGF-Releasing Hydrogel in Fulminant Hepatic Failure

  2015cites this paper
• Analysis of glial fibrillary acidic protein (GFAP)-expressing ductular cells in a rat liver cirrhosis model induced by repeated injections of thioacetamide (TAA).

  2015influential citation
• Hepatocyte Growth Factor Mediates the Antifibrogenic Action of Ocimum bacilicum Essential Oil against CCl4-Induced Liver Fibrosis in Rats

  2015cites this paper
• Epigenetic modifications by histone deacetylases: Biological implications and therapeutic potential in liver fibrosis.

  2015cites this paper
• Prolonged exposure of cholestatic rats to complete dark inhibits biliary hyperplasia and liver fibrosis.

  2014cites this paper
• Role of platelets in chronic liver disease and acute liver injury

  2014cites this paper
• Cellular mechanisms of myofibroblast differentiation and dysfunctions in wound healing

  2014cites this paper
• Cellular and molecular mechanisms in liver fibrogenesis.

  2014cites this paper
• A lipoperoxidação plasmática como preditor de esteatohepatite não alcoólica em obesos mórbidos com doença hepática gordurosa não alcoólica

  2014cites this paper
• Hepatocyte growth factor in dampening liver immune‐mediated pathology in acute viral hepatitis without compromising antiviral activity

  2014cites this paper
• Co-culture of hepatocytes with mesenchymal stem cells for cellular therapy in liver disease

  2014cites this paper
• Mechanisms of fibrogenesis in liver cirrhosis: The molecular aspects of epithelial-mesenchymal transition.

  2014cites this paper
• Virus infection, inflammation and prevention of cancer.

  2014cites this paper
• Loss of Gab 1 adaptor protein in hepatocytes aggravates experimental liver fibrosis in mice

  2014cites this paper
• Immunohistochemical study for the origin of ductular reaction in chronic liver disease.

  2014cites this paper
• Conditional loss of heparin-binding EGF-like growth factor results in enhanced liver fibrosis after bile duct ligation in mice.

  2013cites this paper
• Deletion of clock gene Per2 exacerbates cholestatic liver injury and fibrosis in mice.

  2013cites this paper
• Insulin-like growth factor 1 enhances bile-duct proliferation and fibrosis in Abcb4(-/-) mice.

  2013cites this paper
• Hepatic PPARs: their role in liver physiology, fibrosis and treatment.

  2013cites this paper